SeraNovo is a pharma firm that offers a unique technological platform to increase the bioavailability of water-insoluble medicines. Their proprietary technologies include enhancing bioavailability and reducing development time for the clinic. Their technology harnesses the unique benefits of deep eutectic solvents to create powerful, tailor-made solubility-enhancing formulations that are well tolerated and simple to produce.
Something looks off?